259 related articles for article (PubMed ID: 21802410)
21. A novel stilbene-like compound that inhibits melanoma growth by regulating melanocyte differentiation and proliferation.
Stueven NA; Schlaeger NM; Monte AP; Hwang SL; Huang CC
Toxicol Appl Pharmacol; 2017 Dec; 337():30-38. PubMed ID: 29042215
[TBL] [Abstract][Full Text] [Related]
22. Pax3 functions at a nodal point in melanocyte stem cell differentiation.
Lang D; Lu MM; Huang L; Engleka KA; Zhang M; Chu EY; Lipner S; Skoultchi A; Millar SE; Epstein JA
Nature; 2005 Feb; 433(7028):884-7. PubMed ID: 15729346
[TBL] [Abstract][Full Text] [Related]
23. Adhesion, migration and communication in melanocytes and melanoma.
Haass NK; Smalley KS; Li L; Herlyn M
Pigment Cell Res; 2005 Jun; 18(3):150-9. PubMed ID: 15892711
[TBL] [Abstract][Full Text] [Related]
24. Phosphorylation of PAX3 contributes to melanoma phenotypes by affecting proliferation, invasion, and transformation.
Iyengar AS; Miller PJ; Loupe JM; Hollenbach AD
Pigment Cell Melanoma Res; 2014 Sep; 27(5):846-8. PubMed ID: 24903325
[No Abstract] [Full Text] [Related]
25. Pax3 function is required specifically for inner ear structures with melanogenic fates.
Kim H; Ankamreddy H; Lee DJ; Kong KA; Ko HW; Kim MH; Bok J
Biochem Biophys Res Commun; 2014 Mar; 445(3):608-14. PubMed ID: 24565836
[TBL] [Abstract][Full Text] [Related]
26. Investigation of downstream target genes of PAX3c, PAX3e and PAX3g isoforms in melanocytes by microarray analysis.
Wang Q; Kumar S; Mitsios N; Slevin M; Kumar P
Int J Cancer; 2007 Mar; 120(6):1223-31. PubMed ID: 17187370
[TBL] [Abstract][Full Text] [Related]
27. Microphthalmia-associated transcription factor regulates skin melanoblast migration by repressing the melanoma cell adhesion molecule.
Rao C; Su Z; Li H; Ma X; Zheng X; Liu Y; Lu F; Qu J; Hou L
Exp Dermatol; 2016 Jan; 25(1):74-6. PubMed ID: 26284703
[No Abstract] [Full Text] [Related]
28. FGF2 regulates melanocytes viability through the STAT3-transactivated PAX3 transcription.
Dong L; Li Y; Cao J; Liu F; Pier E; Chen J; Xu Z; Chen C; Wang RA; Cui R
Cell Death Differ; 2012 Apr; 19(4):616-22. PubMed ID: 21997191
[TBL] [Abstract][Full Text] [Related]
29. Haplosufficiency of PAX3 for melanoma development in Tyr: NRASQ61K; Cdkn2a-/- mice allows identification and sorting of melanoma cells using a Pax3GFP reporter allele.
Campagne C; Reyes-Gomez E; Loiodice S; Gadin S; Ezagal J; Bernex F; Abitbol M; Louise A; Beermann F; Panthier JJ; Aubin-Houzelstein G; Egidy G
Melanoma Res; 2016 Feb; 26(1):12-20. PubMed ID: 26587692
[TBL] [Abstract][Full Text] [Related]
30. Pax3 and regulation of the melanocyte-specific tyrosinase-related protein-1 promoter.
Galibert MD; Yavuzer U; Dexter TJ; Goding CR
J Biol Chem; 1999 Sep; 274(38):26894-900. PubMed ID: 10480898
[TBL] [Abstract][Full Text] [Related]
31. Transfection of melanoma cells with antisense PAX3 oligonucleotides additively complements cisplatin-induced cytotoxicity.
He SJ; Stevens G; Braithwaite AW; Eccles MR
Mol Cancer Ther; 2005 Jun; 4(6):996-1003. PubMed ID: 15956257
[TBL] [Abstract][Full Text] [Related]
32. Inhibition of PAX3 by TGF-beta modulates melanocyte viability.
Yang G; Li Y; Nishimura EK; Xin H; Zhou A; Guo Y; Dong L; Denning MF; Nickoloff BJ; Cui R
Mol Cell; 2008 Nov; 32(4):554-63. PubMed ID: 19026785
[TBL] [Abstract][Full Text] [Related]
33. PAX3 is expressed in human melanomas and contributes to tumor cell survival.
Scholl FA; Kamarashev J; Murmann OV; Geertsen R; Dummer R; Schäfer BW
Cancer Res; 2001 Feb; 61(3):823-6. PubMed ID: 11221862
[TBL] [Abstract][Full Text] [Related]
34. Tumor necrosis factor receptor superfamily member TROY is a novel melanoma biomarker and potential therapeutic target.
Spanjaard RA; Whren KM; Graves C; Bhawan J
Int J Cancer; 2007 Mar; 120(6):1304-10. PubMed ID: 17187358
[TBL] [Abstract][Full Text] [Related]
35. p54nrb is a new regulator of progression of malignant melanoma.
Schiffner S; Zimara N; Schmid R; Bosserhoff AK
Carcinogenesis; 2011 Aug; 32(8):1176-82. PubMed ID: 21642354
[TBL] [Abstract][Full Text] [Related]
36. Beyond MITF: Multiple transcription factors directly regulate the cellular phenotype in melanocytes and melanoma.
Seberg HE; Van Otterloo E; Cornell RA
Pigment Cell Melanoma Res; 2017 Sep; 30(5):454-466. PubMed ID: 28649789
[TBL] [Abstract][Full Text] [Related]
37. Developmental pathways activated in melanocytes and melanoma.
Liu J; Fukunaga-Kalabis M; Li L; Herlyn M
Arch Biochem Biophys; 2014 Dec; 563():13-21. PubMed ID: 25109840
[TBL] [Abstract][Full Text] [Related]
38. Nuclear hormone receptor functions in keratinocyte and melanocyte homeostasis, epidermal carcinogenesis and melanomagenesis.
Hyter S; Indra AK
FEBS Lett; 2013 Mar; 587(6):529-41. PubMed ID: 23395795
[TBL] [Abstract][Full Text] [Related]
39. PAX3 and ETS1 synergistically activate MET expression in melanoma cells.
Kubic JD; Little EC; Lui JW; Iizuka T; Lang D
Oncogene; 2015 Sep; 34(38):4964-74. PubMed ID: 25531327
[TBL] [Abstract][Full Text] [Related]
40. Biology of tumor progression in human melanocytes.
Herlyn M; Clark WH; Rodeck U; Mancianti ML; Jambrosic J; Koprowski H
Lab Invest; 1987 May; 56(5):461-74. PubMed ID: 3553733
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
